Breaking the mold: flourishing multicenter trials in Canada  - CellCAN Panel of Experts at the TMM 2017!

(Contents are available in English only/Contenu disponible en anglais uniquement) 

Some of the challenges and opportunities of multicenter clinical trials were addressed by the panel of experts: preclinical trial design, manufacturing and shipping logistics, ethics, regulatory and costs.

November 7, 2017: CellCAN hosted a workshop at the Till&McCulloch Meetings in Mont-Tremblant. ‘’Breaking the mold: flourishing multicenter trials in Canada’’. It was a full house and attendees were able to learn from an empirical perspective the key factors for success in running multicenter clinical trials in Canada.

Dr. David Courtman (Ontario Hospital Research Institute), Dr. Imran Ahmad (CIUSS-de-l’est-de-l’Île-de-Montréal), Vasiliki Rahimzadeh, PhD(c) (McGill University) and Dr. Nadine Kolas, Senior Policy Analyst (Health Canada) came together in a panel moderated by Craig Hasilo, Chief Scientific Officer of CellCAN.

Missed it? The presentations & summaries are exclusively available here!

Make sure to subscribe to our mailing list at the bottom of this page to know when and where our next workshops will be held!

Please fill up this quick survey to access the contents! 

First name
Last name

I agree to receive correspondence from CellCAN, including emails, until I decide to unsubscribe by writing to

I would like to be informed of future events organized by CellCAN or its partners.



You have questions regarding your health, or the health of a loved one, wondering what cell therapy or regenerative medicine can do for you? Looking for solutions for your research projects? We can put the strength of our network at your service. Write to us!


There are many types of stem cells.